Franco Merckling
Director Ejecutivo en Kenta Biotech AG .
Origen de la red de primer grado Franco Merckling.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.
11
| Private Company | Biotechnology | 11 |
| Private Company | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Franco Merckling a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Aventis, Inc. | Corporate Officer/Principal | ||
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GIVAUDAN SA | Food: Specialty/Candy | Chief Executive Officer | |
| BACHEM HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Sunstar-Holding AG
 Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Hotels/Resorts/Cruise lines | Director/Board Member Chairman | |
Ingro Finanz AG
 Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The company is based in Bubendorf, Switzerland. | Financial Conglomerates | Chairman | |
| Boston University | College/University | Graduate Degree | |
Rentschler Arzneimittel GmbH
 Rentschler Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Part of MEDICE Arzneimittel Pütter GmbH & Co. KG, Rentschler Arzneimittel GmbH is a German company that manufactures over-the-counter drugs. The company is based in Laupheim, Germany. Rentschler Arzneimittel was acquired by MEDICE Arzneimittel Pütter GmbH & Co. KG from Dr. Rentschler Holding GmbH & Co. KG on March 16, 2006. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Schering GmbH & Co. Produktions KG
 Schering GmbH & Co. Produktions KG Pharmaceuticals: MajorHealth Technology Schering GmbH & Co. Produktions KG manufactures medicines for treating disorders of the menstrual cycle. The company's product Primolut N contains norethisterone which is a progestogen (a female hormone) used to treat irregular, painful or heavy periods. It is also used in the treatment of endometriosis (presence of tissue from the lining of the womb in places where it is not normally found). Schering GmbH was founded in 1851 and is headquartered in Weimar, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Varuma AG | Corporate Officer/Principal | ||
| Loyola University of Chicago | College/University | Corporate Officer/Principal | |
| INSEAD | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Graduate Degree | |
| DOTTIKON ES HOLDING AG | Chemicals: Specialty | Director/Board Member | |
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| University of Fribourg | College/University | Undergraduate Degree | |
| University of Bayreuth | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Pharmaceuticals: Major | Chairman | |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Bern | College/University | Doctorate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree | |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Pharmaceuticals: Major | Chairman | |
Harlan Laboratories Ltd.
 Harlan Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Harlan Laboratories Ltd. provides non-clinical contract research, research models and animal diets services to pharmaceutical, biotech, medical device, agrochemical and chemical industry. The company is based in Itingen, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| Fox-Chemicals GmbH | Corporate Officer/Principal | ||
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Ferienclub Privilège AG | Director/Board Member | ||
| MFC Beteiligungs AG | Chairman | ||
| PDS Pathology Data Systems Co. Ag | Chairman | ||
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
Rentschler Immobilien GmbH & Co. KG
 Rentschler Immobilien GmbH & Co. KG Financial ConglomeratesFinance Rentschler Immobilien GmbH & Co. KG provides investment services. The private company is based in Laupheim, Germany. The CEO of the German company is Nikolaus Friedrich Rentschler. | Financial Conglomerates | Chief Executive Officer | |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler. | Financial Conglomerates | Chief Executive Officer | |
Rentschler Beteiligungs GmbH
 Rentschler Beteiligungs GmbH Financial ConglomeratesFinance Rentschler Beteiligungs GmbH is an investment holding German company. The private company is based in Laupheim, Germany. The CEOs are Nikolaus Friedrich Rentschler, Jürgen Müller. The company was founded in 1998. | Financial Conglomerates | Chief Executive Officer | |
Vaderis Therapeutics AG
 Vaderis Therapeutics AG BiotechnologyHealth Technology Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd. | Biotechnology | Chief Operating Officer | |
| Data Systems AG | Chairman |
Estadísticas
Internacional
| Suiza | 29 |
| Alemania | 12 |
| Estados Unidos | 8 |
| Países Bajos | 2 |
| Francia | 2 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 5 |
| Process Industries | 3 |
Operativa
| Corporate Officer/Principal | 26 |
| Director/Board Member | 24 |
| Chairman | 15 |
| Chief Executive Officer | 10 |
| Doctorate Degree | 6 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Franco Merckling
- Conexiones Empresas
